Understanding how DNA repairs itself and developing new technologies for this process
Integrative single molecule studies: DNA repair and technology development
This study is looking at how our body's proteins help fix DNA to prevent mistakes that can lead to cancer and other diseases, with the hope of finding better treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11098668 on NIH RePORTER |
What this research studies
This research focuses on using advanced single-molecule techniques to explore the intricate processes involved in DNA repair. By examining how proteins interact with DNA during repair, the study aims to uncover the mechanisms that prevent genomic mutations and improve responses to cancer treatments. The research also investigates the role of DNA mismatch repair proteins in both cancer and neurodegenerative diseases, providing insights that could lead to better therapeutic strategies. Patients may benefit from the development of new treatments that enhance DNA repair mechanisms.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with hereditary cancer syndromes, such as Lynch syndrome, or those affected by neurodegenerative diseases linked to DNA repair mechanisms.
Not a fit: Patients with conditions unrelated to DNA repair processes or those not affected by cancer or neurodegenerative diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer therapies and better management of genetic disorders.
How similar studies have performed: Previous research has shown promise in using single-molecule techniques to study DNA repair, indicating that this approach could yield valuable insights.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Erie, Dorothy a — Univ of North Carolina Chapel Hill
- Study coordinator: Erie, Dorothy a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.